These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 3551968

  • 1. Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure.
    Nakano T, Morimoto Y, Kakuta Y, Konishi T, Kodera T, Kanamaru M, Takezawa H.
    Arzneimittelforschung; 1986 Dec; 36(12):1829-34. PubMed ID: 3551968
    [Abstract] [Full Text] [Related]

  • 2. [Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure].
    Nakano T, Isaka N, Konishi T, Tekezawa H, Morimoto Y, Kakuta Y, Kodera T, Kanamaru M.
    Kokyu To Junkan; 1987 May; 35(5):553-9. PubMed ID: 3112884
    [No Abstract] [Full Text] [Related]

  • 3. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure.
    Gavazzi A, Mussini A, Bramucci E.
    Arzneimittelforschung; 1986 Feb; 36(2A):366-70. PubMed ID: 3707652
    [Abstract] [Full Text] [Related]

  • 4. Hemodynamic evaluation of ibopamine in patients with refractory congestive heart failure.
    Humar F, Morgera T, Maras P, Camerini F.
    Arzneimittelforschung; 1986 Feb; 36(2A):360-2. PubMed ID: 3707650
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
    Dei Cas L, Metra M, Nodari S, Visioli O.
    J Cardiovasc Pharmacol; 1989 Feb; 14 Suppl 8():S111-7. PubMed ID: 2483436
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
    Sannia L, Ibba GV, Castellaccio M, Dore L.
    Arzneimittelforschung; 1986 Feb; 36(2A):355-9. PubMed ID: 3707649
    [Abstract] [Full Text] [Related]

  • 7. [Atrial natriuretic factor, catecholamines and the renin-angiotensin system in cardiac insufficiency. Relation to hemodynamic parameters].
    Komajda M, Carayon A, Nguyen JP, Maistre G, Drobinski G, Legrand S, Landault C, Legrand JC, Grosgogeat Y.
    Arch Mal Coeur Vaiss; 1988 Jul; 81(7):845-53. PubMed ID: 2973293
    [Abstract] [Full Text] [Related]

  • 8. [Acute and chronic effects of a new oral inotropic agent, ibopamine hydrochloride, on hemodynamic and metabolic responses to ergometer exercise in patients with severe congestive heart failure].
    Morimoto Y, Kasai A, Nagano K, Umino M, Kakuta Y, Iwata J, Hamada M, Konishi T, Nakano T.
    Kokyu To Junkan; 1989 Jul; 37(7):773-8. PubMed ID: 2799097
    [Abstract] [Full Text] [Related]

  • 9. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
    Mitrovic V, Neuzner J, Opper H, Thormann J, Schlepper M.
    Z Kardiol; 1994 Jul; 83 Suppl 2():37-48. PubMed ID: 8091823
    [Abstract] [Full Text] [Related]

  • 10. Onset of cardiovascular action after oral ibopamine. Early hemodynamic effects of single and repeated doses in patients with idiopathic dilated myocardiopathy.
    Di Mario C, Compostella L, Iavernaro A, Libardoni M, Ghirardi P, Cucchini F.
    Arzneimittelforschung; 1990 Jun; 40(6):661-6. PubMed ID: 2397001
    [Abstract] [Full Text] [Related]

  • 11. Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure.
    Avanzini Z, Bellogini GC, Brusoni B, Ciampani N, Dei Cas L, Gazzola U, Maggi GC, Mangiavacchi M, Metra M, Pinca L.
    Arzneimittelforschung; 1986 Feb; 36(2A):394-7. PubMed ID: 3707656
    [Abstract] [Full Text] [Related]

  • 12. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M, Stanek B, Frey B, Berger R, Rödler S, Siegel A, Hartter E, Schuller M, Ogris E, Pacher R.
    J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
    [Abstract] [Full Text] [Related]

  • 13. [Blood levels of activated renin, aldosterone, catecholamine in congestive heart failure. II. Effects of dopaminergic stimulation with a dopamine agonist: ibopamine].
    Melloni R, Scarazatti E, Gandini C, Melloni GF.
    Boll Soc Ital Biol Sper; 1987 Dec 31; 63(12):1121-8. PubMed ID: 3331290
    [No Abstract] [Full Text] [Related]

  • 14. Effects of ibopamine on peripheral hemodynamics: a strain gauge plethysmographic study in patients with congestive heart failure.
    Musacci GF, Ansani L, Toselli T, Aggio S, Baracca E, Longhini C.
    Arzneimittelforschung; 1986 Feb 31; 36(2A):380-2. PubMed ID: 3707654
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of acute hemodynamic effects and pharmacokinetic behaviour of ibopamine in patients with severe heart failure.
    De Vita C, Triulzi E, Devizzi S, Colombo G, Palvarini M, Pocchiari F, Pataccini R.
    Arzneimittelforschung; 1986 Feb 31; 36(2A):349-54. PubMed ID: 3707648
    [Abstract] [Full Text] [Related]

  • 16. Low-dose enoximone therapy in pre-transplant patients: hemodynamic, echocardiographic, and neurohumoral findings.
    Park JW, Heinzler R, Wirtz JH, Fieten-Rumswinkel M, Braun P, May E, Hetzer R, Heinrich KW.
    Z Kardiol; 1994 Feb 31; 83 Suppl 2():49-53. PubMed ID: 8091824
    [Abstract] [Full Text] [Related]

  • 17. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.
    Pediatrics; 2006 Jul 31; 118(1):e76-84. PubMed ID: 16751617
    [Abstract] [Full Text] [Related]

  • 18. Positive inotropic effects of ibopamine in patients with congestive heart failure. A multicenter investigation.
    Caponnetto S, Allegro A, Bellotti G, Cataldi A, Salvemini M, Portioli I, Prati PL, Gambelli G, Boccanelli A, Zacharo E.
    Arzneimittelforschung; 1986 Feb 31; 36(2A):386-90. PubMed ID: 3518725
    [Abstract] [Full Text] [Related]

  • 19. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V, Seferovic P, Dodic S, Krotin M, Neskovic A, Dickstein K, de Voogd H, Böcker C, Ziegler D, Godes M, Nakov R, Essers H, Verboom C, Hocher B.
    Circ Heart Fail; 2009 Nov 31; 2(6):523-31. PubMed ID: 19919976
    [Abstract] [Full Text] [Related]

  • 20. Hemodynamic and neurohumoral effects of ketanserin, a 5-HT2 receptor antagonist in patients with congestive heart failure.
    Majid PA, Morris WM, Sole MJ.
    Can J Cardiol; 1987 Mar 31; 3(2):70-4. PubMed ID: 3567710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.